Haloperidol blocks dorsal striatum activity but not analgesia in a placebo paradigm

Cortex

Volumn 57, Issue , 2014, Pages 60-73

  Wrobel, Nathalie ^a,c   Wiech, Katja ^b   Forkmann, Katarina ^c   Ritter, Christoph ^a,c   Bingel, Ulrike ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Dopamine; FMRI; Haloperidol; Pain; Placebo analgesia

Indexed keywords

HALOPERIDOL; PLACEBO; DOPAMINE RECEPTOR BLOCKING AGENT;

ADULT; ANALGESIA; ANTERIOR CINGULATE; ARTICLE; BASAL GANGLION; BEHAVIOR CHANGE; BOLD SIGNAL; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; HUMAN; INFERIOR PARIETAL LOBULE; INSULA; LEARNING; MALE; NEUROTRANSMISSION; NOCICEPTION; NORMAL HUMAN; ORBITAL CORTEX; PAIN; PAIN THRESHOLD; PLACEBO EFFECT; PREFRONTAL CORTEX; PRIMARY SOMATOSENSORY CORTEX; REWARD; SECONDARY SOMATOSENSORY CORTEX; THALAMUS; ADOLESCENT; BRAIN; BRAIN MAPPING; DRUG EFFECTS; IMAGE PROCESSING; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANALGESIA; BRAIN; BRAIN MAPPING; DOPAMINE ANTAGONISTS; FEMALE; HALOPERIDOL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; PAIN; PLACEBOS; YOUNG ADULT;

EID: 84899718573     PISSN: 00109452     EISSN: 19738102     Source Type: Journal    
DOI: 10.1016/j.cortex.2014.02.023     Document Type: Article

References (60)

1. Amanzio M., Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. The Journal of Neuroscience 1999, 19(1):484-494.
2. Ardekani B.A., Bachman A.H., Helpern J.A. A quantitative comparison of motion detection algorithms in fMRI. Magnetic Resonance Imaging 2001, 19(7):959-963.
3. Becker S., Ceko M., Louis-Foster M., Elfassy N.M., Leyton M., Shir Y., et al. Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteers. PLoS One 2013, 8(11):e80766. 10.1371/journal.pone.0080766.
4. Bentley P., Husain M., Dolan R.J. Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Neuron 2004, 41(6):969-982.
5. Bingel U., Glascher J., Weiller C., Buchel C. Somatotopic representation of nociceptive information in the putamen: an event-related fMRI study. Cerebral Cortex 2004, 14(12):1340-1345. 10.1093/cercor/bhh094.
6. Bingel U., Lorenz J., Schoell E., Weiller C., Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006, 120(1-2):8-15. 10.1016/j.pain.2005.08.027.
7. Bingel U., Schoell E., Herken W., Buchel C., May A. Habituation to painful stimulation involves the antinociceptive system. Pain 2007, 131(1-2):21-30. 10.1016/j.pain.2006.12.005.
8. Bond A., Lader M. The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 1974, 47(3):211-218. 10.1111/j.2044-8341.1974.tb02285.x.
9. Colloca L., Benedetti F. How prior experience shapes placebo analgesia. Pain 2006, 124(1-2):126-133. 10.1016/j.pain.2006.04.005.
10. Colloca L., Sigaudo M., Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008, 136(1-2):211-218. 10.1016/j.pain.2008.02.006.
11. Cooper J.C., Dunne S., Furey T., O'Doherty J.P. Human dorsal striatum encodes prediction errors during observational learning of instrumental actions. Journal of Cognitive Neuroscience 2012, 24(1):106-118. 10.1162/jocn_a_00114.
12. Crowne D.P., Marlowe D. A new scale of social desirability independent of psychopathology. Journal of Consulting Psychology 1960, 24:349-354.
13. Djaldetti R., Shifrin A., Rogowski Z., Sprecher E., Melamed E., Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004, 62(12):2171-2175.
14. Eippert F., Bingel U., Schoell E.D., Yacubian J., Klinger R., Lorenz J., et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009, 63(4):533-543. 10.1016/j.neuron.2009.07.014.
15. Faymonville M.E., Laureys S., Degueldre C., DelFiore G., Luxen A., Franck G., et al. Neural mechanisms of antinociceptive effects of hypnosis. Anesthesiology 2000, 92(5):1257-1267.
16. Frankenstein U.N., Richter W., McIntyre M.C., Remy F. Distraction modulates anterior cingulate gyrus activations during the cold pressor test. NeuroImage 2001, 14(4):827-836. 10.1006/nimg.2001.0883.
17. Friston K.J., Ashburner J., Frith C.D., Poline J.-B., Heather J.D., Frackowiak R.S.J. Spatial registration and normalization of images. Human Brain Mapping 1995, 3(3):165-189.
18. Friston K.J., Holmes A.P., Price C.J., Buchel C., Worsley K.J. Multisubject fMRI studies and conjunction analyses. NeuroImage 1999, 10(4):385-396. 10.1006/nimg.1999.0484.
19. Fruhstorfer H., Lindblom U., Schmidt W.C. Method for quantitative estimation of thermal thresholds in patients. Journal of Neurology, Neurosurgery & Psychiatry 1976, 39(11):1071-1075.
20. de la Fuente-Fernández R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001, 293(5532):1164-1166. 10.1126/science.1060937.
21. Gerdelat-Mas A., Simonetta-Moreau M., Thalamas C., Ory-Magne F., Slaoui T., Rascol O., et al. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. Journal of Neurology, Neurosurgery & Psychiatry 2007, 78(10):1140-1142. 10.1136/jnnp.2007.120212.
22. Gierthmühlen J., Lienau F., Maag R., Hagenah J.M., Deuschl G., Fritzer E., et al. Somatosensory processing in a German family with PINK1 mutations: its potential role in Parkinson disease. Journal of Neurology, Neurosurgery & Psychiatry 2009, 80(5):571-574. 10.1136/jnnp.2008.158659.
23. Gläscher, J., & Gitelman, D. (2008). Contrast weights in flexible factorial design with multiple groups of subjects. SPM@ JISCMAIL. AC. UK Sml, editor.
24. Grevert P., Albert L.H., Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain 1983, 16(2):129-143.
25. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Någren K., Hietala J., et al. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 2002, 99(1-2):273-279. 10.1016/s0304-3959(02)00121-5.
26. Haruno M., Kawato M. Different neural correlates of reward expectation and reward expectation error in the putamen and caudate nucleus during stimulus-action-reward association learning. Journal of Neurophysiology 2006, 95(2):948-959. 10.1152/jn.00382.2005.
27. Hautzinger M., Bailer M. ADS Allgemeine Depressionsskala 1993, Beltz Test.
28. Honey G., Bullmore E. Human pharmacological MRI. Trends in Pharmacological Sciences 2004, 25(7):366-374. 10.1016/j.tips.2004.05.009.
29. Leslie R.A., James M.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends in Pharmacological Sciences 2000, 21(8):314-318.
30. Levine J.D., Gordon N.C. Influence of the method of drug administration on analgesic response. Nature 1984, 312(5996):755-756.
31. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet 1978, 2(8091):654-657.
32. Lin M.T., Wu J.J., Chandra A., Tsay B.L. Activation of striatal dopamine receptors induces pain inhibition in rats. Journal of Neural Transmission 1981, 51(3-4):213-222.
33. Magnusson J.E., Fisher K. The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum. Brain Research 2000, 855(2):260-266. 10.1016/s0006-8993(99)02396-3.
34. Marsh R., Hao X., Xu D., Wang Z., Duan Y., Liu J., et al. A virtual reality-based FMRI study of reward-based spatial learning. Neuropsychologia 2010, 48(10):2912-2921. 10.1016/j.neuropsychologia.2010.05.033.
35. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiological Reviews 1998, 78(1):189-225.
36. Montgomery G.H., Kirsch I. Classical conditioning and the placebo effect. Pain 1997, 72(1-2):107-113.
37. Moore R.Y., Whone A.L., Brooks D.J. Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study. Neurobiology of Disease 2008, 29(3):381-390. http://dx.doi.org/10.1016/j.nbd.2007.09.004.
38. O'Doherty J.P. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Current Opinion in Neurobiology 2004, 14(6):769-776. 10.1016/j.conb.2004.10.016.
39. O'Doherty J., Dayan P., Schultz J., Deichmann R., Friston K., Dolan R.J. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 2004, 304(5669):452-454. 10.1126/science.1094285.
40. Oei N.Y., Rombouts S.A., Soeter R.P., van Gerven J.M., Both S. Dopamine modulates reward system activity during subconscious processing of sexual stimuli. Neuropsychopharmacology 2012, 37(7):1729-1737. 10.1038/npp.2012.19.
41. Pessiglione M., Seymour B., Flandin G., Dolan R.J., Frith C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006, 442(7106):1042-1045. 10.1038/nature05051.
42. Petrovic P. Opioid and placebo analgesia share the same network. Seminars in Pain Medicine 2005, 3(1):31-36. 10.1016/j.spmd.2005.02.005.
43. Pleger B., Ruff C.C., Blankenburg F., Kloppel S., Driver J., Dolan R.J. Influence of dopaminergically mediated reward on somatosensory decision-making. PLoS Biology 2009, 7(7):e1000164. 10.1371/journal.pbio.1000164.
44. Schultz W. Predictive reward signal of dopamine neurons. Journal of Neurophysiology 1998, 80(1):1-27.
45. Schweinhardt P., Seminowicz D.A., Jaeger E., Duncan G.H., Bushnell M.C. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. Journal of Neuroscience 2009, 29(15):4882-4887. 10.1523/JNEUROSCI.5634-08.2009.
46. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.K. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 2007, 55(2):325-336. 10.1016/j.neuron.2007.06.028.
47. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Archives of General Psychiatry 2008, 65(2):220-231. 10.1001/archgenpsychiatry.2007.34.
48. Spielberger C.D., Gorsuch R.L., Lushene R.E. Manual for the state-trait anxiety inventory 1970, Consulting Psychologist Press, Palo Alto, CA.
49. Taylor T.N., Caudle W.M., Shepherd K.R., Noorian A., Jackson C.R., Iuvone P.M., et al. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of Neuroscience 2009, 29(25):8103-8113. 10.1523/jneurosci.1495-09.2009.
50. Tremblay A.M., Desmond R.C., Poulos C.X., Zack M. Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls. Addiction Biology 2011, 16(3):467-484. 10.1111/j.1369-1600.2010.00208.x.
51. Volkow N.D., Wang G.-J., Fowler J.S., Logan J., Jayne M., Franceschi D., et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002, 44(3):175-180. 10.1002/syn.10075.
52. Voudouris N.J., Peck C.L., Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain 1990, 43(1):121-128.
53. Wager T.D., Atlas L.Y., Leotti L.A., Rilling J.K. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. Journal of Neuroscience 2011, 31(2):439-452.
54. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004, 303(5661):1162-1167. 10.1126/science.1093065.
55. Wager T.D., Scott D.J., Zubieta J.K. Placebo effects on human mu-opioid activity during pain. Proceedings of the National Academy of Sciences U S A 2007, 104(26):11056-11061. 10.1073/pnas.0702413104.
56. Wise R.A. Action of drugs of abuse on brain reward systems. Pharmacology, Biochemistry, and Behavior 1980, 13(1):213-223.
57. Worsley K.J., Friston K.J. Analysis of fMRI time-series revisited-again. NeuroImage 1995, 2(3):173-181.
58. Xu X., Fukuyama H., Yazawa S., Mima T., Hanakawa T., Magata Y., et al. Functional localization of pain perception in the human brain studied by PET. Neuroreport 1997, 8(2):555-559.
59. Zald D.H., Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter G.S., et al. Dopamine transmission in the human striatum during monetary reward tasks. Journal of Neuroscience 2004, 24(17):4105-4112. 10.1523/JNEUROSCI.4643-03.2004.
60. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. Journal of Neuroscience 2005, 25(34):7754-7762. 10.1523/JNEUROSCI.0439-05.2005.